You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Brazil Patent: 112022002202


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112022002202

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,833,164 Jan 11, 2042 Amicus Therap Us GALAFOLD migalastat hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Drug Patent BR112022002202

Last updated: August 1, 2025

Introduction

The patent BR112022002202 encompasses a pharmaceutical invention filed within Brazil’s patent system, offering insights into innovation trends, scope of protection, and competitive landscape within the Brazilian pharmaceutical sector. This analysis examines the patent's scope, claim structure, and the broader patent landscape, facilitating strategic decision-making for stakeholders such as pharmaceutical companies, patent attorneys, and investors.

Patent Overview and Filing Context

Brazil’s patent system, governed by the National Institute of Industrial Property (INPI), follows procedures aligned with the Patent Cooperation Treaty (PCT) and TRIPS agreement, emphasizing innovation and access control. Patent BR112022002202 was granted or published following detailed examination, revealing the technological field—likely pharmaceuticals involving specific compounds, formulations, or manufacturing processes.

The patent's filing date, priority claims, and related patent families shape its position within the competitive landscape, impacting subsequent innovation, licensing opportunities, and generic entry.

Scope of the Patent

Technological Field and Purpose

Although the explicit claims are unspecified here, typical pharmaceutical patents in Brazil cover:

  • Novel compounds with therapeutic activity.
  • Pharmaceutical formulations enhancing bioavailability or stability.
  • Manufacturing methods for efficient or safer drug production.
  • Use claims covering novel therapeutic indications or methods.

The scope's breadth heavily depends on the language and breadth of independent claims, which ideally balance protection of core innovations with sufficient breadth to deter competitors.

Claim Structure and Classification

Brazilian patents often follow a hierarchical claim structure:

  • Independent Claims: Define broad protections—likely covering specific chemical entities or methods.
  • Dependent Claims: Narrow protections, detailing specific embodiments, dosage forms, or manufacturing parameters.

This patent likely employs chemical classes or specific compounds, aligning with classifications such as the International Patent Classification (IPC) A61K (Preparations for medical, dental, or toilet purposes), possibly augmented by subclasses indicating particular formulations or chemical modifications.

Claims Analysis

Claim Breadth and Limitations

  • Core Innovation Claims: Focused on unique chemical molecules or specific formulations. For example, a new chemical entity with enhanced therapeutic efficacy or reduced side effects.
  • Method-of-Use Claims: Covering novel therapeutic applications, expanding market scope.
  • Process Claims: For manufacturing steps that improve yield, purity, or cost-effectiveness.

The scope of protection hinges on how comprehensive these claims are. Broad claims provide wider protection but may face validity challenges if anticipated or obvious. Narrow claims offer precise rights but are easier to design around.

Defensive and Offensive Layers

Patent strategies often include multiple layers:

  • Primary Claims: Protect the core innovation.
  • Secondary Claims: Cover variants or modifications.
  • Use Claims: Extend protection to different therapeutic indications or formulations.

Analyzing the claims’ wording for terms like "comprising," "consisting of," or "wherein" indicates scope flexibility or specificity. The use of open language (e.g., "comprising") generally broadens protection.

Patent Landscape in Brazil and Global Context

Competitive Patents and Innovation Trends

Brazil’s pharmaceutical patent landscape is characterized by:

  • Incremental Innovations: Focused on formulations and methods to navigate patent cliffs and generic competition.
  • Biotech and Novel Compounds: Growing interest, though often facing stringent examination for novelty and inventive step.
  • Patent Thickets: Multiple patents targeting similar therapeutic areas, creating barriers to entry.

Globally, Brazil aligns with international standards but maintains a cautious approach balancing patent rights and public health.

Prior Art and Patentability

Brazilian patent examiners rigorously assess prior art, including:

  • Publications in scientific journals
  • Existing patents worldwide
  • Previous disclosures

The patent’s validity depends on demonstrating novelty and inventive step over prior art in both domestic and international contexts. Successful patents typically demonstrate significant improvements over existing compounds or methods.

Freedom-to-Operate and Patent Encumbrances

Stakeholders must evaluate whether the patent overlaps with other rights, especially considering:

  • Existing patents in similar therapeutic areas
  • Patent families covering formulations or manufacturing techniques
  • Potential licensing or litigation risks

Brazil’s patent landscape favors defensive patenting for minor modifications, emphasizing the need for due diligence.

Implications for Stakeholders

Pharmaceutical Companies

  • Can leverage this patent to secure market exclusivity for a specific drug or formulation.
  • Should assess the scope to avoid infringement and identify licensing opportunities.
  • Must analyze potential challenges to patent validity, especially if claims are broad.

Legal and Patent Strategists

  • Need to scrutinize claim language for scope and enforceability.
  • Should monitor related patent filings for similar inventions.
  • Develop strategies around patent prosecution, oppositions, and potential invalidations.

Investors and Market Analysts

  • Use patent landscape data to gauge innovation intensity.
  • Assess risks related to patent expiry or infringement.
  • Identify growth segments driven by protected innovations.

Conclusion

Brazilian patent BR112022002202 presents a substantial claim set likely focused on a novel pharmaceutical compound or formulation. Its scope defines the strategic positioning within Brazil’s evolving patent landscape, where robust claims underpin market exclusivity. Competitors must analyze the claims’ breadth and related patents to craft effective legal and R&D strategies.

Understanding the patent’s landscape—specifically how it integrates with existing patents, formulation trends, and innovation strategies—fits into broader assessments of market potential and legal risks. The patent’s strength depends on detailed claim language, prior art considerations, and ongoing examination insights.

Key Takeaways

  • The patent’s scope determines its ability to protect core innovations and deter competitors.
  • Broad, well-defined claims enhance enforceability but must navigate patentability standards.
  • Brazil’s patent landscape is dynamic, with increasing activity in biotech and formulations.
  • Due diligence is critical in assessing potential infringement or invalidity risks.
  • Strategic patenting in Brazil requires balancing robust protection with acknowledgment of existing prior art.

FAQs

1. How does the scope of a patent impact its enforceability in Brazil?
A well-drafted, broad scope allows stronger enforcement against infringers but must align with existing prior art to withstand legal challenges. Narrow claims, while easier to defend, offer limited market protection.

2. What are the common challenges faced during patent examination in Brazil?
Challenges include establishing novelty over prior art, inventive step, clarity of claims, and patentable subject matter, especially given Brazil’s stringent examination standards.

3. How does Brazil’s patent law influence innovation in pharmaceuticals?
Brazil’s law supports patenting novel and inventive pharmaceutical inventions, promoting local innovation while balancing public health interests through compulsory licensing provisions.

4. What should companies consider when analyzing a patent landscape?
They should evaluate overlapping patents, claim scope, potential patent expirations, licensing opportunities, and upcoming filings to inform R&D and commercialization strategies.

5. Can patents filed in Brazil be enforced internationally?
No; enforcement is jurisdiction-specific. However, patent filings in Brazil can be part of broader international patent strategies, such as via PCT applications, to secure global protection.


Sources:

[1] INPI Official Website – Patent Examination Procedures and Guidelines
[2] World Intellectual Property Organization (WIPO) Patent Landscape Reports
[3] Brazilian Patent Law (Law No. 9,279/1996)
[4] Patent Classification Databases – IPC Codes (A61K)
[5] Industry Reports on Brazilian Pharmaceutical Innovation Trends

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.